CTRI/2018/02/012126
Completed
未知
A Prospective, Interventional Clinical Study to evaluate the efficacy and safety of Jolly Tulsi 51 drops for Boosting Immune system and Detoxification in healthy subjects.
Jolly Health Care0 sites30 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Jolly Health Care
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Healthy Male and female subjects who has taken at least 3 course any type antibiotics in the past 3 months.
- •2\.Pregnant women will be included in the study.
- •3\. Mentally, physically and legally eligible to give informed consent.
- •4\. Male and female BMI between 18\.0 â?? 30\.0 kg/m2
- •5\. Subjects is willing and able to comply with all trial requirements
- •6\. Subjects who have not participated in a similar investigation in the past three months
- •7\. Normal thyroid function
Exclusion Criteria
- •1\. Subjects with history or presence of cancer
- •2\. Subjects with history of a psychiatric disorder and or drug or alcohol abuse or dependency;
- •3\. Subjects having a known intolerance to gluten or lactose
- •4\. Subjects having a known allergy to any ingredient in the investigational product
- •5\. Subjects with Medical history of gastrointestinal bleeding or gastric or duodenal ulcer.
- •6\. Subjects having any other medical condition which, in the opinion of the investigator, could interfere with participation in the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
Clinical study to assess the role of Homoeopathic medicines in the management of GoutCTRI/2024/04/065433Dr M P K Homoeopathic Medical College Hospital and Research Centre
Completed
Phase 3
Effectiveness of Homoeopathic medicines in Hypertrophied AdenoidCTRI/2019/11/022163DR SHAREENA C P30
Recruiting
Not Applicable
Prospective interventional clinical study to evaluate the efficacy and safety of atezolizumab plus bevacizumab in combination with carbon ion radiotherapy for unresectable hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000051549Yamagata University20
Completed
Not Applicable
Compare addition of Local anaesthetic in distension medium for decreasing pain during hysteroscopyHealth Condition 1: N972- Female infertility of uterine originHealth Condition 2: N859- Noninflammatory disorder of uterus, unspecifiedCTRI/2021/08/035773Teerthankar Mahaveer Medical college and research centre120
Not yet recruiting
Not Applicable
To study the effectiveness of individualized homoeopathic medicine in cases of sciatica.CTRI/2024/05/067967Sainath Hospital